Specialised Human Cell Line Recombinant Factor VIII
key details
| Value | £4,140,000 |
|---|---|
| Status | cancelled |
| Category (CPV) | 33141530 |
| Contract start | 1 Oct 2017 |
| Contract end | 30 Sept 2018 |
| SME suitable | Yes |
| OCID | ocds-b5fd17-3d64322e-b2c1-4714-b683-c1138aec3b39 |
description
Specialised Human Cell Line Recombinant Factor VIII
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 31 Mar 2017 | Planning (planning) | · | 756ee002-deb5-45d5-92de-e3c2a470a7aa-139032 |
more from DEPARTMENT OF HEALTH
- Care Provider Delivery Partner · £50,000 · 22 Jun 2021
- Contract for the supply of Td-IPV · 14 Dec 2020
- Herpes zoster (shingles) vaccines purchased, held centrally and distributed by the Department of Health in support of the immunisation programme · 11 Jun 2020
- Strategic stockpile of medicines 2021 · 3 Jun 2020
- Herpes zoster (shingles) vaccines purchased, held centrally and distributed by the Department of Health in support of the immunisation programme · 21 May 2020
- Strategic stockpile of medicines 2021 · 21 May 2020
- Contract for the supply of rotavirus vaccine · 9 Apr 2020
- Contract for the supply of DTAP_IPV+Hib · 30 Jan 2020
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Purchase of Diathermy · Leeds Teaching Hospitals NHS Trust · £48,000
- Bleeding Disorders including Haemophilia B · NHS England · £250,000,000
- Provision of R-Phycoerythrin F(ab)2-specific IgG antibody · Public Health England · £130,000
- NHS Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B · NHS England · £192,000,000
- Provision of R-Phycoerythrin F(ab)2-specific IgG antibody · Public Health England · £44,601
- National Framework Agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders · NHS England · £302,000,000
- HOME DELIVERY OF RECOMBINANT COAGULATION FACTORS FOR HAEMOPHILIA PATIENTS · University Hospitals of North Midlands NHS Trust
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.